We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

StemFit® Feeder Free Medium ES/iPS Cell Culture

Product News   Apr 01, 2020

 
StemFit® Feeder Free Medium ES/iPS Cell Culture
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Thermo Fisher Scientific and Q2 Solutions Partner to Deliver Clinical Trial Results Faster

Product News

Q2 Solutions has announced its partnership with Thermo Fisher Scientific to deliver clinical trial lab results economically with unprecedented speed.

READ MORE

IRBM’s Advent Manufactures 13,000 Doses of COVID-19 Vaccine for Use in Phase 2/3 Clinical Trials

Product News

Advent has manufactured 13,000 doses of the novel COVID-19 vaccine candidate, ChAdOx1 nCoV-19 (now known as AZD1222) for use in the Phase 2/3 clinical trial COV002 by the University of Oxford.

READ MORE

Phase I/II Clinical Trial of COVID-19 Vaccine Begins

Product News

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE